History of does Desmoid tumor. Evaluate for progression. ABDOMEN:LIVER, BILIARY TRACT: T2 hyperintense segment 7 focus demonstrating arterial enhancement without washout, unchanged. No additional focal liver lesion. Stable mild common bile duct prominence without a focal lesion or stone. Normally distended gallbladder.SPLEEN: The spleen measures 12.4 cm in craniocaudal length without a focal lesion.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: No significant abnormality noted.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: Mass centered in the small bowel mesentery measures 6.1 x 4.0 cm (series 22/376) compared to 6.2 x 3.5 cm previously. The mass encases the SMV and SMA which remain patent.BONES, SOFT TISSUES: Broad-based ventral hernias in the central and right abdomen without evidence of complication.OTHER: No significant abnormality noted.PELVIS:UTERUS, ADNEXA: The uterus is lobular and enlarged containing multiple masses. A mass in the right uterine fundus measuring 6.9 x 3.6 cm has imaging features which are somewhat atypical for leiomyoma. The endometrial canal is thickened an heterogeneous with postcontrast enhancement. Nabothian cysts.BLADDER: No significant abnormality noted.LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.No significant interval change in the small bowel mesentery mass which encases the SMA and SMV.2.Enlarged lobular uterus containing multiple masses most of which demonstrate signal characteristics typical of leiomyomata, however a right fundal mass is somewhat atypical (increased T2-weighted signal intensity restricted diffusion and lobular heterogeneous enhancement) and demonstrates gradual growth since 2013. 3.Also the endometrium/individual cavity is heterogeneously thickened with postcontrast enhancement, which may be seen in the proliferative phase of the menstrual cycle, however given the patient's age correlation clinically for endometrial pathology is recommended.